Skip to main content
Client Work

Edesa Biotech Inc. closes US$3 million private placement

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Edesa Biotech Inc.

On November 3, 2022, Edesa Biotech Inc., a Canadian clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, completed a US$3 million private placement of units, priced at-the-market.

Fasken acted for Edesa Biotech Inc., with a team led by Wojtek Baraniak and Myroslav Chwaluk, and which included Alexis Shamess and Arjun Sodhi (Articling Student).

Jurisdiction

  • Ontario

Team

    Subscribe

    Receive email updates from our team

    Subscribe